Variant report
Variant | rs567181486 |
---|---|
Chromosome Location | chr19:41681134-41681135 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:41666000-41681800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr19:41677600-41681600 | Enhancers | Fetal Intestine Large | intestine |
3 | chr19:41678400-41681800 | Enhancers | Duodenum Mucosa | Duodenum |
4 | chr19:41678800-41681600 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr19:41678800-41681600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr19:41679000-41681400 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr19:41679000-41681800 | Enhancers | Placenta | Placenta |
8 | chr19:41679200-41681200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr19:41679200-41681200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr19:41679200-41681800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
11 | chr19:41679200-41681800 | Enhancers | Fetal Intestine Small | intestine |
12 | chr19:41679400-41681600 | Weak transcription | H1 Cell Line | embryonic stem cell |
13 | chr19:41679400-41681600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr19:41679400-41681800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr19:41679800-41681600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr19:41680200-41681800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr19:41680200-41682800 | Enhancers | Stomach Mucosa | stomach |
18 | chr19:41680400-41682400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr19:41680600-41681200 | Active TSS | Fetal Stomach | stomach |
20 | chr19:41680600-41681400 | Flanking Active TSS | HepG2 | liver |
21 | chr19:41680600-41681600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
22 | chr19:41680600-41681800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
23 | chr19:41680600-41681800 | Active TSS | Rectal Mucosa Donor 29 | rectum |
24 | chr19:41680600-41682800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
25 | chr19:41680600-41683000 | Enhancers | Placenta Amnion | Placenta Amnion |
26 | chr19:41680800-41681200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
27 | chr19:41680800-41681400 | Flanking Active TSS | A549 | lung |
28 | chr19:41680800-41682200 | Enhancers | Esophagus | oesophagus |
29 | chr19:41680800-41682600 | Weak transcription | Colonic Mucosa | Colon |
30 | chr19:41680800-41683400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
31 | chr19:41681000-41681200 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
32 | chr19:41681000-41681400 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
33 | chr19:41681000-41681400 | Weak transcription | Hela-S3 | cervix |
34 | chr19:41681000-41681600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
35 | chr19:41681000-41681600 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
36 | chr19:41681000-41681600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
37 | chr19:41681000-41681600 | Weak transcription | Brain Hippocampus Middle | brain |
38 | chr19:41681000-41681800 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
39 | chr19:41681000-41681800 | Weak transcription | Gastric | stomach |
40 | chr19:41681000-41681800 | Weak transcription | Lung | lung |
41 | chr19:41681000-41681800 | Enhancers | NHEK | skin |
42 | chr19:41681000-41682000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |